Literature DB >> 11875991

Warfarin therapy in a patient homozygous for the CYP2C9 3 allele.

Jacob Ablin1, Shaltiel Cabili, Ayala Lagziel, Hava Peretz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11875991

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


× No keyword cloud information.
  2 in total

1.  Clinically actionable genotypes among 10,000 patients with preemptive pharmacogenomic testing.

Authors:  S L Van Driest; Y Shi; E A Bowton; J S Schildcrout; J F Peterson; J Pulley; J C Denny; D M Roden
Journal:  Clin Pharmacol Ther       Date:  2013-11-19       Impact factor: 6.875

2.  Prevalence of clinically actionable genotypes and medication exposure of older adults in the community.

Authors:  Nilofar Daneshi; Elizabeth Holliday; Stephen Hancock; Jennifer J Schneider; Rodney J Scott; John Attia; Elizabeth A Milward
Journal:  Pharmgenomics Pers Med       Date:  2017-01-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.